S. Lütje, D. Gerrits, J. Molkenboer-Kuenen, K. Herrmann, G. Fracasso, M. Colombatti, O. Boerman and S. Heskamp. "Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.", 2018. AbstractDOIPMID
2017
Papers in international journals
S. Heskamp, L. Heijmen, D. Gerrits, J. Molkenboer-Kuenen, E. Ter Voert, K. Heinzmann, D. Honess, D. Smith, J. Griffiths, S. Doblas, R. Sinkus, P. Laverman, W. Oyen, A. Heerschap and O. Boerman. "Response Monitoring with [(18)F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases.", 2017. AbstractDOIPMID
S. Heskamp, R. Hernandez, J. Molkenboer-Kuenen, M. Essler, F. Bruchertseifer, A. Morgenstern, E. Steenbergen, W. Cai, C. Seidl, W. McBride, D. Goldenberg and O. Boerman. "α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.", 2017. AbstractDOIPMID
2016
Papers in international journals
K. Chatalic, S. Heskamp, M. Konijnenberg, J. Molkenboer-Kuenen, G. Franssen, M. Clahsen-van Groningen, M. Schottelius, H. Wester, W. van Weerden, O. Boerman and M. de Jong. "Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent.", 2016. AbstractDOIPMID
2015
Papers in international journals
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, C. Wauters, L. Strobbe, C. Mandigers, P. Bult, W. Oyen, W. van der Graaf and H. van Laarhoven. "Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.", 2015. AbstractDOIPMID
S. Heskamp, W. Hobo, J. Molkenboer-Kuenen, D. Olive, W. Oyen, H. Dolstra and O. Boerman. "Non-invasive imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies", 2015. Abstract/PDFDOIPMID
2014
Papers in international journals
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, F. Sweep, A. Geurts-Moespot, M. Engelhardt, W. van der Graaf, W. Oyen and H. van Laarhoven. "Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without altering VEGF expression", 2014. Abstract/PDFDOIPMID
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, R. Koornstra, S. Linn, W. Oyen, W. van der Graaf and H. van Laarhoven. "Dynamics of IGF-1R Expression During Endocrine Breast Cancer Treatment", 2014. Abstract/PDFDOIPMID
2013
Papers in international journals
E. Fleuren, Y. Versleijen-Jonkers, S. Heskamp, M. Roeffen, W. Bouwman, J. Molkenboer-Kuenen, H. van Laarhoven, W. Oyen, O. Boerman and W. van der Graaf. "The strength of small: improved targeting of insulin-like growth factor-1 receptor (IGF-1R) with F(ab')â‚‚-R1507 fragments in Ewing sarcomas", 2013. Abstract/PDFDOIPMID
S. Heskamp, O. Boerman, J. Molkenboer-Kuenen, W. Oyen, W. van der Graaf and H. van Laarhoven. "Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies", 2013. AbstractDOIPMID
2012
Papers in international journals
S. Heskamp, H. van Laarhoven, J. Molkenboer-Kuenen, W. Bouwman, W. van der Graaf, W. Oyen and O. Boerman. "Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507", 2012. Abstract/PDFDOIPMID
F. van de Watering, J. Molkenboer-Kuenen, O. Boerman, J. van den Beucken and J. Jansen. "Differential loading methods for BMP-2 within injectable calcium phosphate cement", 2012. Abstract/PDFDOIPMID
2011
Papers in international journals
B. Hoeben, J. Molkenboer-Kuenen, W. Oyen, W. Peeters, J. Kaanders, J. Bussink and O. Boerman. "Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model", 2011. AbstractDOIPMID
E. Fleuren, Y. Versleijen-Jonkers, A. van de Luijtgaarden, J. Molkenboer-Kuenen, S. Heskamp, M. Roeffen, H. van Laarhoven, P. Houghton, W. Oyen, O. Boerman and W. van der Graaf. "Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507", 2011. AbstractDOIPMID
2010
Papers in international journals
S. Heskamp, H. van Laarhoven, J. Molkenboer-Kuenen, G. Franssen, Y. Versleijen-Jonkers, W. Oyen, W. van der Graaf and O. Boerman. "ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model", 2010. Abstract/PDFDOIPMID
2005
Papers in international journals
F. van Schaijk, E. Oosterwijk, J. Molkenboer-Kuenen, A. Soede, B. McBride, D. Goldenberg, W. Oyen, F. Corstens and O. Boerman. "Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models", 2005. AbstractPMID